These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8556255)

  • 1. Treatment of telangiectasia macularis eruptiva perstans with the 585-nm flashlamp-pumped dye laser.
    Ellis DL
    Dermatol Surg; 1996 Jan; 22(1):33-7. PubMed ID: 8556255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telangiectasia macularis eruptiva perstans.
    Nguyen NQ
    Dermatol Online J; 2004 Nov; 10(3):1. PubMed ID: 15748571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired bilateral telangiectasia macularis eruptiva perstans: A unique clinical feature of photodamaging rather than a subtype of cutaneous mastocytosis.
    Moon HR; Kim YJ; Jung JM; Won CH; Lee MW; Choi JH; Chang SE
    J Dermatol; 2017 Nov; 44(11):1276-1280. PubMed ID: 28646532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ringed telangiectasias: an unusual presentation of telangiectasia macularis eruptiva perstans.
    Siddique L; Ahrns H; Seiverling E
    BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29196283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telangiectasia macularis eruptiva perstans (TMEP): A form of cutaneous mastocytosis with potential systemic involvement.
    Severino M; Chandesris MO; Barete S; Tournier E; Sans B; Laurent C; Apoil PA; Lamant L; Mailhol C; Laroche M; Fraitag S; Hanssens K; Dubreuil P; Hermine O; Paul C; Bulai Livideanu C
    J Am Acad Dermatol; 2016 May; 74(5):885-91.e1. PubMed ID: 26899198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telangiectasia macularis eruptiva perstans.
    Gibbs NF; Friedlander SF; Harpster EF
    Pediatr Dermatol; 2000; 17(3):194-7. PubMed ID: 10886750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telangiectasia macularis eruptiva perstans: a neglected type of mastocytosis with exclusively cutaneous involvement? A case series.
    Michelerio A; Grassi S; Elena C; Croci GA; Boveri E; Bossi G; Brazzelli V
    Eur J Dermatol; 2019 Apr; 29(2):174-178. PubMed ID: 30973331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of telangiectasia macularis eruptiva perstans with total skin electron beam radiation.
    Monahan TP; Petropolis AA
    Cutis; 2003 May; 71(5):357-9. PubMed ID: 12769402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telangiectasia macularis eruptiva perstans presented as a pseudoallergic food reaction.
    Vidal C; del Rio E; Suárez-Peñaranda J; Armisén M
    J Investig Allergol Clin Immunol; 2000; 10(4):248-50. PubMed ID: 11039843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation of telangiectasia macularis eruptiva perstans as a long-standing solitary plaque associated with renal carcinoma.
    Pascual JC; Bañuls J; Albares MP; Vergara G; Belinchón I; Silvestre JF; Betlloch I
    J Cutan Med Surg; 2003; 7(5):399-402. PubMed ID: 14973646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telangiectasia macularis eruptiva perstans: a case report and review of the literature.
    Sarkany RP; Monk BE; Handfield-Jones SE
    Clin Exp Dermatol; 1998 Jan; 23(1):38-9. PubMed ID: 9667109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unilateral telangiectasia macularis eruptiva perstans of the breast.
    Patel N; Stranahan D; Fenske NA
    Cutis; 2012 Jul; 90(1):26-8. PubMed ID: 22908729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telangiectasia macularis eruptiva perstans with an associated myeloproliferative disorder.
    Martin LK; Romanelli P; Ahn YS; Kirsner RS
    Int J Dermatol; 2004 Dec; 43(12):922-4. PubMed ID: 15569020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cases of telangiectasia macularis eruptiva perstans demonstrated by immunohistochemistry for c-kit (CD 117).
    Lee HW; Jeong YI; Choi JC; Lee MW; Choi JH; Moon KC; Koh JK
    J Dermatol; 2005 Oct; 32(10):817-20. PubMed ID: 16361734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telangiectasia Macularis Eruptiva Perstans: Report of Three Cases.
    Tumer G; Jow T; McElligott S; Schwartz RA; Lambert WC
    Skinmed; 2017; 15(3):171-174. PubMed ID: 28705275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual cutaneous findings of urticaria pigmentosa and telangiectasia macularis eruptiva perstans associated with marked myelofibrosis.
    Turchin I; Barankin B; Schloss E
    Int J Dermatol; 2006 Oct; 45(10):1215-7. PubMed ID: 17040445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telangiectasia macularis eruptiva perstans: more than skin deep.
    Watkins CE; Bokor WB; Leicht S; Youngberg G; Krishnaswamy G
    Dermatol Reports; 2011 Jan; 3(1):e12. PubMed ID: 25386256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual presentation of telangiectasia macularis eruptiva perstans at the site of healed herpes zoster; Wolf's isotopic response.
    Sarsik S; Soliman SH; Elhalaby RE
    Australas J Dermatol; 2023 Aug; 64(3):e237-e240. PubMed ID: 37318879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telangiectasia Macularis Eruptiva Perstans in a 55-Year-Old Female With Type 2 Diabetes Mellitus.
    Alhammad NS; Alshehri S; Alawadi TM; Ragaban A; Alyahya FS; Alharbi A
    Cureus; 2024 Mar; 16(3):e57333. PubMed ID: 38690480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telangiectasia macularis eruptive perstans successfully treated with PUVA therapy.
    Sotiriou E; Apalla Z; Ioannides D
    Photodermatol Photoimmunol Photomed; 2010 Feb; 26(1):46-7. PubMed ID: 20070840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.